|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61F 2/02 | (2006.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61L 31/06 | (2006.01) | ||
| A61L 31/16 | (2006.01) | ||
| A61M 31/00 | (2006.01) | ||
| A61F 9/00 | (2006.01) |
| (11) | Number of the document | 3290024 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17183171.2 |
| Date of filing the European patent application | 2012-08-29 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161528736 P | 2011-08-29 | US | |
| 201261644397 P | 2012-05-08 | US |
| (72) |
CADDEN, Suzanne, CA
HAO, Yong, CA
UTKHEDE, Deepank, CA
RUBINCHIK, Valery, CA
KJELLBOTN, Charles Richard, CA
|
| (73) |
Mati Therapeutics Inc.,
4317 Dunning Lane, Austin, TX 78746,
US
|
| (54) | SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |
| SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |